Arabic Arabic English English French French German German
dark

Eisai Alzheimer’s Disease Pipeline Research, Including New Lecanemab (BAN2401) Data, to be Presented at 2021 Alzheimer’s Association International Conference (AAIC)

Eisai Inc. announced today the presentation of findings from the company’s robust Alzheimer’s disease (AD) pipeline, including lecanemab (BAN2401). Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Welocalize Celebrates its 19th Acquisition as Next Level Globalization Joins

Next Post

Hiscox boss Bronek Masojada to retire – successor revealed

Related Posts
Total
0
Share